The Claim

Liraglutide, when added to metformin, increases first-phase insulin secretion (AIRg) by approximately 3-fold (497 mU×L⁻¹×min) and improves the disposition index (DI) by 1-fold (766 units) in overweight/obese patients with newly diagnosed type 2 diabetes and stable coronary artery disease, indicating enhanced beta-cell function independent of changes in insulin sensitivity or glucose effectiveness.

Source: Liraglutide effects on beta‐cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
67score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In overweight or obese patients with newly diagnosed type 2 diabetes and stable coronary artery disease, adding liraglutide to metformin increases first-phase insulin secretion by about three times and doubles the disposition index, reflecting improved beta-cell function without changes in insulin sensitivity or glucose effectiveness.

See the scientific wording

Liraglutide, when added to metformin, increases first-phase insulin secretion (AIRg) by approximately 3-fold (497 mU×L⁻¹×min) and improves the disposition index (DI) by 1-fold (766 units) in overweight/obese patients with newly diagnosed type 2 diabetes and stable coronary artery disease, indicating enhanced beta-cell function independent of changes in insulin sensitivity or glucose effectiveness.

Why this might work

Liraglutide binds to receptors on insulin-producing cells in the pancreas, which triggers a chain of signals inside the cells that increases calcium levels. This calcium surge causes the cells to release stored insulin rapidly in response to food intake, improving the initial burst of insulin without changing how the body uses insulin or clears sugar.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Liraglutide effects on beta‐cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes

    This study found that adding liraglutide to metformin helps the pancreas release insulin faster after eating in people with type 2 diabetes and heart disease, without making their bodies any better at using insulin or clearing sugar. So yes, it improves the pancreas’s job directly.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.